临床路径在乳腺癌诊疗中的应用  

Application of Clinical Pathways in the Diagnosis and Treatment of Breast Cancer

作　　者：赵蕾[1] 王力红[2] 李小莹[2] 仇叶龙[2] 张科峰[3] 刘春玲[4] 邓英梅[4] 

机构地区：[1]首都医科大学宣武医院内分泌科 [2]首都医科大学宣武医院医务处 [3]首都医科大学宣武医院心脏科 [4]首都医科大学宣武医院病案统计科

出　　处：《中国病案》2012年第10期54-55,共2页Chinese Medical Record

基　　金：北京市哲学社会科学规划项目(编号:10AaZH196)

摘　　要：目的分析评价乳腺癌入院患者临床路径实施前后的治疗效果和住院费用。方法采用历史同期对照方法,将175例临床路径组患者与166例常规治疗组患者的各项医疗指标进行对比分析。结果临床路径组与常规治疗组治愈率、好转率基本相同;路径组平均住院日比常规组少4.44天;次均住院费用有所下降,药品费用下降明显。结论乳腺癌临床路径在有效保证医疗质量的前提下,对缩短住院日、规范诊疗行为、降低住院费用具有非常重要的意义。Objective To analyze and assess the therapeutic effect and hospitalization expenses with the application of clinical pathway in the treat- ment of breast cancer. Me~ Use the before- after treatment （BAT）, make a contrast on the medical relative indexes between clinical pathway group （CPg） of 175 patients and routine treatment group （RTg） of 166 patients. Results The curative and improvement rate of CPg and RTg were al- most the same, but the stay length of CPg was 4.44 days less compared with RTg, the average hospitalization cost decreased mildly, and drug cost dropped rapidly. Conclusions Under the premise that maintaining effective medical quality, the implementation of clinical pathway plays an important role in the decrease of stay length, standardize treatment behavior and reduce the cost of inpatients.

关 键 词：乳腺癌 临床路径 应用 评价 

分 类 号：R737.9[医药卫生—肿瘤]